UCI to conduct all anti-doping controls
All anti-doping testing at the Amgen Tour of California will be done by the International Cycling Union (UCI), with none to be done by the US Anti-Doping Agency. An agreement between the two agencies to split the duties fell through at the last minute.
The Tour, which starts on Sunday in South Lake Tahoe, had announced in February that the USADA would, for the first time, conduct both the pre-competition and in-competition testing.
"As previously announced, it was USADA's intention to conduct a comprehensive and independent pre-competition and in-competition testing program," read a USADA statement. "The pre-competition testing program performed by USADA has been implemented. USADA had hoped to conduct the in-competition testing program at the 2011 Tour of California but was unable to finalize the agreement previously reached with the UCI. As has historically been the case, the International Cycling Union [UCI] will conduct their own testing program during the competition."
The February announcement promised “the most comprehensive anti-doping program in the history of the race”.
According to Espn.com, the UCI decided that USADA would be allowed to collect samples, but not conduct targeted testing or get the test results. The USADA refused to go along with these conditions, and the agreement fell apart.
"Following recent discussions between the UCI and USADA concerning anti-doping arrangements for the 2011 Amgen Tour of California, the UCI wishes to announce that no agreement was reached by the parties," the UCI said in a statement on its website. "As a consequence, the USADA will take no part in the anti-doping controls; these will be conducted by the UCI throughout the event."